Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-07-037182
Filing Date
2007-06-04
Accepted
2007-06-04 08:09:13
Documents
1
Period of Report
2007-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd161189.html 4  
1 FORM 4 rrd161189.xml 4 4670
  Complete submission text file 0001181431-07-037182.txt   6698
Mailing Address SPOORSTRAAT 50 KJ VENLO P7 5911
Business Address SPOORSTRAAT 50 KJ VENLO P7 5911 31-77-320-8400
QIAGEN NV (Reporting) CIK: 0001015820 (see all company filings)

State of Incorp.: P7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-32393 | Film No.: 07895796
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 17841 FITCH IRVINE CA 92614
Business Address 5525 SOUTH 900 E SUITE 110 SALT LAKE CITY UT 84117 949 250 8686
eGENE, INC. (Issuer) CIK: 0001105409 (see all company filings)

EIN.: 870645507
SIC: 2834 Pharmaceutical Preparations